OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cerebrospinal fluid characteristics of patients treated with intrathecal nusinersen for spinal muscular atrophy
Rotem Orbach, Liora Sagi, Efraim Sadot, et al.
Muscle & Nerve (2022) Vol. 66, Iss. 6, pp. 762-766
Open Access | Times Cited: 7
Rotem Orbach, Liora Sagi, Efraim Sadot, et al.
Muscle & Nerve (2022) Vol. 66, Iss. 6, pp. 762-766
Open Access | Times Cited: 7
Showing 7 citing articles:
The impact of three SMN2 gene copies on clinical characteristics and effect of disease-modifying treatment in patients with spinal muscular atrophy: a systematic literature review
Claudia Dosi, Riccardo Masson
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 9
Claudia Dosi, Riccardo Masson
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 9
Identifying Biomarkers of Spinal Muscular Atrophy for Further Development
Jacqueline Glascock, Basil T. Darras, Thomas O. Crawford, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 5, pp. 937-954
Open Access | Times Cited: 16
Jacqueline Glascock, Basil T. Darras, Thomas O. Crawford, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 5, pp. 937-954
Open Access | Times Cited: 16
Molecular Biomarkers for the Diagnosis, Prognosis, and Pharmacodynamics of Spinal Muscular Atrophy
Marija Babić, Maria Banović, Ivana Berečić, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5060-5060
Open Access | Times Cited: 13
Marija Babić, Maria Banović, Ivana Berečić, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 15, pp. 5060-5060
Open Access | Times Cited: 13
Insights into spinal muscular atrophy from molecular biomarkers
Xiaodong Xing, Xinzhu Liu, Xiandeng Li, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 1849-1863
Open Access | Times Cited: 3
Xiaodong Xing, Xinzhu Liu, Xiandeng Li, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 1849-1863
Open Access | Times Cited: 3
Symptomatic intracranial hypertension in an adult patient with spinal muscular atrophy and arachnoid cysts receiving nusinersen
Gerrit Machetanz, Marc Grziwotz, Luisa Semmler, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 4, pp. 719-725
Open Access | Times Cited: 7
Gerrit Machetanz, Marc Grziwotz, Luisa Semmler, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 4, pp. 719-725
Open Access | Times Cited: 7
Molecular markers of disease severity and response to nusinersen therapy in 5q spinal muscular atrophy (literature review)
Konstantin Popov, Т. М. Алексеева, В. Д. Назаров, et al.
Neuromuscular Diseases (2023) Vol. 13, Iss. 3, pp. 33-39
Open Access | Times Cited: 1
Konstantin Popov, Т. М. Алексеева, В. Д. Назаров, et al.
Neuromuscular Diseases (2023) Vol. 13, Iss. 3, pp. 33-39
Open Access | Times Cited: 1
